Mupadolimab, a promising molecule, is attracting increasing interest within the research community due to its unique mechanism of activity. This CD73-blocking therapeutic selectively blocks CD73, an cell-surface https://bookmark-template.com/story29257226/a-new-mupadolimab-an-innovative-anti-cd73-antibody-reveals-potential